.

Investor

OncoCyte Senior Management Rings NYSE Opening Bell

Investor Relations

OncoCyte is focused on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer.

 

 

 

Corporate Profile

 

OncoCyte Chairman and CEO at Bell ringing ceremony

Stock Information
Events & Presentation

No upcoming events scheduled at this time.

Latest News
OncoCyte Corporation to Present at the 2016 Aegis Growth Conference
OncoCyte to Present Initial Data on its Breast Cancer Diagnostic Test at the Prestigious San Antonio Breast Cancer Symposium